# Integrating Dermocosmetics Into Acne Care in Latin America

**Authors:** Patricia Troielli, Jorge Moreno, Andrea Cortes, Paola Cardenas, Delphine Kerob, Adriana Gamarra, Brigitte Dreno

PMC · DOI: 10.1111/jocd.70776 · Journal of Cosmetic Dermatology · 2026-03-01

## TL;DR

This review explores how dermocosmetics can be used alongside or instead of prescription treatments for acne in Latin America, offering a balance between effectiveness and skin tolerance.

## Contribution

The paper provides expert guidance on integrating dermocosmetics into acne care, particularly for milder cases and sensitive skin.

## Key findings

- Dermocosmetics can serve as effective alternatives or adjuncts to prescription acne treatments.
- They are especially useful for milder acne and in cases of sensitive skin or poor medication tolerance.
- Using dermocosmetics can improve adherence and reduce skin irritation from prescription therapies.

## Abstract

Prescription acne products have proven efficacy and safety, yet management can pose a challenge. This review discusses the benefits of adding dermocosmetics to acne management.

We add expert consensus with review of the literature to provide guidance for clinicians managing patients with acne in Latin America.

There is increasing evidence that dermocosmetics (over‐the‐counter cleansers, moisturizers, and sunscreens that contain acne‐targeting ingredients) can be a good alternative to prescription acne treatments as well as adjuncts. Milder forms of acne may be present in any age patient, but prepubertal acne and acne cosmetica may be particularly well suited to a dermocosmetic approach. More severe acne may need a dermocosmetic added if there is sensitive skin or poor tolerance to prescription medications, and when the patient or family does not wish to use antibiotics or other acne prescription treatments. Dermocosmetics may be used as adjuncts to any type of prescription therapy, but may be most effective when used with products associated with skin irritation such as topical retinoids or benzoyl peroxide. Appropriate dermocosmetics can also fortify the skin barrier and help to protect the skin microbiome.

Acne management is complex and there can be adherence, tolerability, and efficacy problems. Dermocosmetics alone can be used in milder forms of acne or in maintenance post treatment, as a good compromise between efficacy and tolerability. As adjuncts, dermocosmetics can also decrease skin irritation and thereby increase adherence, can enhance the efficacy of prescription therapies, and can normalize dysbiosis in acne.

## Linked entities

- **Chemicals:** benzoyl peroxide (PubChem CID 7187)
- **Diseases:** acne (MONDO:0011438)

## Full-text entities

- **Genes:** TREM2 (triggering receptor expressed on myeloid cells 2) [NCBI Gene 54209] {aka AD17, PLOSL2, TREM-2, Trem2a, Trem2b, Trem2c}, PEE1 (preeclampsia/eclampsia 1) [NCBI Gene 5177] {aka PEE, PIH, PREG1}
- **Diseases:** laxity (MESH:D007593), Acne (MESH:D000152), hyperandrogenism (MESH:D017588), alopecia (MESH:D000505), acanthosis nigricans (MESH:D000052), hyperpigmentation (MESH:D017495), skin disorder (MESH:D012871), hirsutism (MESH:D006628), inflammation (MESH:D007249), dysbiosis (MESH:D064806), cutaneous irritation (MESH:D001523)
- **Chemicals:** lipid (MESH:D008055), minocycline (MESH:D008911), benzoyl peroxide (MESH:D001585), isotretinoin (MESH:D015474), spironolactone (MESH:D013148), licochalcone A (MESH:C070840), adapalene (MESH:D000068816), L carnitine (MESH:D002331), 2-oleamideo-1,3-octadecanediol (-), thiamidol (MESH:C000718227), vitamin K (MESH:D014812), squalene (MESH:D013185), retinoids (MESH:D012176), tranexamic acid (MESH:D014148), niacinamide (MESH:D009536), zinc (MESH:D015032), salicylic acid (MESH:D020156), glycolic acid (MESH:C031149), EGCG (MESH:C045651), piroctone olamine (MESH:C052599), omega 3 fatty acids (MESH:D015525)
- **Species:** Homo sapiens (human, species) [taxon 9606], Staphylococcus epidermidis (species) [taxon 1282], Cutibacterium acnes (species) [taxon 1747]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12951007/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12951007/full.md

## References

43 references — full list in the complete paper: https://tomesphere.com/paper/PMC12951007/full.md

---
Source: https://tomesphere.com/paper/PMC12951007